Equity Method Investments - Schedule of Equity Method Investment (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Schedule of Equity Method Investment [Line Items] | ||
| Equity investment carrying amount, beginning balance | $ 981,830 | |
| Equity investment carrying amount, ending balance | 489,700 | $ 981,830 |
| Equity Method Investments [Member] | ||
| Schedule of Equity Method Investment [Line Items] | ||
| Equity investment carrying amount, beginning balance | 981,830 | 1,534,013 |
| Portion of operating losses recognized | (492,130) | (479,636) |
| Reduction in equity | (283,268) | |
| Share of dilution to new investors | 210,721 | |
| Equity investment carrying amount, ending balance | $ 489,700 | $ 981,830 |
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition Amount of proportionate share of dilution to new investors. No definition available.
|
| X | ||||||||||
- Definition Amount of addition (reduction) to the amount at which an instrument classified in shareholders' equity could be incurred (settled) in a current transaction between willing parties. No definition available.
|
| X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|